Novo Nordisk
NVO
#14
Rank
NZ$969.82 B
Marketcap
$213.46
Share price
0.05%
Change (1 day)
35.59%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of June 2024 : NZ$14.57 B

According to Novo Nordisk's latest financial reports the company has NZ$14.57 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$7.07 B32.4%
2022-12-31NZ$5.34 B37.56%
2021-12-31NZ$3.88 B32.57%
2020-12-31NZ$2.93 B-14.76%
2019-12-31NZ$3.43 B-3.66%
2018-12-31NZ$3.57 B-16.57%
2017-12-31NZ$4.27 B1.14%
2016-12-31NZ$4.23 B-3.55%
2015-12-31NZ$4.38 B32.48%
2014-12-31NZ$3.31 B1.52%
2013-12-31NZ$3.26 B-6.36%
2012-12-31NZ$3.48 B-10.84%
2011-12-31NZ$3.90 B4.8%
2010-12-31NZ$3.72 B8.79%
2009-12-31NZ$3.42 B3.37%
2008-12-31NZ$3.31 B77.25%
2007-12-31NZ$1.87 B45.64%
2006-12-31NZ$1.28 B10.48%
2005-12-31NZ$1.16 B14.21%
2004-12-31NZ$1.01 B26.27%
2003-12-31NZ$0.80 B63.17%
2002-12-31NZ$0.49 B-54.69%
2001-12-31NZ$1.09 B155.15%
2000-12-31NZ$0.42 B18.28%
1999-12-31NZ$0.36 B61.07%
1998-12-31NZ$0.22 B-21.93%
1997-12-31NZ$0.28 B49.61%
1996-12-31NZ$0.19 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$11.47 B-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.43 B-62.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.75 B-26.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.77 B-19.24%๐Ÿ‡ซ๐Ÿ‡ท France